iLive offers a medically supervised tirzepatide program designed for real, lasting results. If you have struggled to lose weight through diet and exercise alone, tirzepatide (the active ingredient in Mounjaro and Zepbound) may be the clinical solution you have been looking for. Our team of medical professionals in Winchester, Virginia creates personalized treatment plans that combine medication management, lifestyle guidance, and ongoing support so you can live the life you want.
Tirzepatide is a prescription injectable medication approved by the FDA for chronic weight management and type 2 diabetes. It is sold under two brand names: Mounjaro (approved for type 2 diabetes management) and Zepbound (approved specifically for weight loss in adults with obesity or overweight with a weight-related health condition).
Unlike older weight loss medications, tirzepatide works by simultaneously activating two hormone receptor pathways in the body: GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1). This dual-action mechanism is what sets it apart from other medications in its class and has made it one of the most clinically significant advances in medical weight loss in recent years.
Tirzepatide works by targeting two hormonal pathways that regulate appetite, metabolism, and blood sugar. Most weight loss medications only target one pathway. Tirzepatide’s dual-receptor approach is the reason it produces significantly greater weight loss than previous-generation medications.
Together, these two mechanisms create a powerful metabolic effect. You eat less because you feel satisfied sooner. Your body processes food more efficiently. Blood sugar stabilizes. Over time, these changes compound into meaningful, sustained weight loss without the white-knuckle effort of extreme calorie restriction.
Both tirzepatide and semaglutide are proven, FDA-approved medications for weight loss. Here is an honest, side-by-side look at how they compare.
| Feature | Tirzepatide | Semaglutide |
|---|---|---|
| Receptor targets | GIP + GLP-1 (dual) | GLP-1 only |
| Administration | Once weekly injection | Once weekly injection |
| FDA weight loss approval | Zepbound (2023) | Wegovy (2021) |
| Average weight loss (clinical | Up to 20 to 22.5% of body | Up to 15% of body weight |
| Blood sugar management | Yes | Yes |
| Approved for type 2 diabetes | Yes (Mounjaro) | Yes (Ozempic) |
| Common side effects | Nausea, GI discomfort | Nausea, GI discomfort |
Clinical data shows that tirzepatide produces greater average weight loss than semaglutide, but both medications are effective and appropriate for different patients. The right choice depends on your health history, any existing conditions, your response to prior treatments, and your personal goals. At iLive, your provider will review your full medical profile and recommend the option best suited to you, without pressure or a one-size-fits-all approach.
Clinical trial results for tirzepatide are among the most impressive in the history of medical weight loss research
In the landmark SURMOUNT-1 trial, participants taking tirzepatide achieved the following results over 72 weeks:
Over one-third of participants on the highest dose lost more than 25% of their body weight.
These outcomes are most consistent when medication is combined with nutritional guidance and activity support, both of which are built into the iLive program.
These outcomes are most consistent when medication is combined with nutritional guidance and activity support, both of which are built into the iLive program.
Tirzepatide is not appropriate for everyone. Candidacy is determined by a thorough medical evaluation at iLive.
Tirzepatide is not appropriate for patients with a personal or family history of medullary thyroid carcinoma, MEN 2, known hypersensitivity to tirzepatide, or certain pancreatitis histories. A full contraindication review is part of every iLive intake evaluation.
Tirzepatide is a prescription medication that activates both GIP and GLP-1 hormone receptors in the body. It is FDA-approved under the brand name Mounjaro for type 2 diabetes and under the brand name Zepbound for chronic weight management in adults with obesity or overweight with a weight-related health condition. It is administered as a once-weekly subcutaneous injection.
Tirzepatide works by activating two hormone receptor systems simultaneously. GLP-1 activation reduces appetite and slows digestion, so you feel full longer. GIP activation improves metabolism and regulates fat storage. Together, these effects reduce caloric intake and improve metabolic function, leading to sustained weight loss over time.
Semaglutide (Ozempic, Wegovy) targets only GLP-1 receptors. Tirzepatide (Mounjaro, Zepbound) targets both GLP-1 and GIP receptors. Clinical trials show tirzepatide produces greater average weight loss. The right medication depends on your individual health history, and your iLive provider will help you determine the best fit.
In the SURMOUNT-1 clinical trial, participants lost an average of 20 to 22.5 percent of their body weight at the highest dose over 72 weeks. Individual results vary depending on dose, adherence, diet, and physical activity. Most patients begin to see results within the first four to eight weeks.
The most common side effects are nausea, diarrhea, vomiting, constipation, and reduced appetite. These typically occur during dose increases and improve over time. Serious but rare risks include pancreatitis, gallbladder problems, and increased heart rate. Your iLive provider will review all risks with you before starting treatment.
Tirzepatide is generally appropriate for adults with a BMI of 30 or greater, or a BMI of 27 or greater with a weight-related health condition such as type 2 diabetes, high blood pressure, or high cholesterol. Eligibility is confirmed through a medical evaluation at iLive.
Yes. iLive offers a medically supervised tirzepatide weight loss program at 27 W Jubal Early Dr,
Winchester, VA 22601. We serve patients from Winchester and surrounding communities including Stephens City, Front Royal, Berryville, Strasburg, Woodstock, Middletown, and Martinsburg, WV.
Call (540) 546-6442 to schedule your consultation.
Meet with an iLive medical provider to discuss your health history, weight loss goals, and any prior treatments. This is a judgment-free conversation focused entirely on your needs.
Your provider reviews your medical history, current medications, BMI, and any relevant lab work. This ensures tirzepatide is safe and appropriate for you.
If you are a good candidate, your provider creates an individualized plan that includes your starting dose, titration schedule, dietary guidance, and activity recommendations.
You receive your tirzepatide prescription and a full walkthrough on how to self-administer your weekly injection correctly and comfortably.
Regular check-ins allow your provider to track your progress, adjust your dose as needed, manage any side effects, and keep your treatment on track.
As you approach your goal weight, your iLive team transitions you into a maintenance phase designed to protect the results you have worked hard to achieve.
These effects are most common during dose initiation or increases and typically improve as your body adjusts.
Your safety is the foundation of everything we do. Your provider reviews your full medical profile before prescribing, monitors your response at every check-in, and is available to address concerns between appointments. We do not prescribe tirzepatide without a proper in-person evaluation.
Every patient receives medically supervised care.
iLive combines the clinical rigor of a medical practice with a patient experience that actually feels supportive. Our providers are experienced in metabolic health and weight management, and they take the time to understand your full picture before recommending any treatment.
We do not hand you a prescription and send you home. Every iLive patient receives a customized plan with dose adjustments, nutritional guidance, and progress tracking built in from day one.
We believe you should know what you are paying before you commit. iLive offers clear program pricing with no hidden fees and no surprise charges. We walk you through your investment at your consultation.
Whether you prefer an in-office visit at our Winchester location or a virtual consultation from the comfort of home, iLive accommodates your schedule and preferences.
Tirzepatide is one part of a broader iLive approach to weight management. Depending on your needs, your plan may also incorporate metabolic testing, body composition analysis, nutritional coaching, and lifestyle programming built to support long-term success, not just short-term loss.
Shenandoah Valley who are navigating the real challenges of weight management. We understand the local community because we are part of it.
iLive is located in Winchester, Virginia and proudly serves patients from across the northern Shenandoah Valley and surrounding areas, including:
If you are searching for a tirzepatide clinic near you in the Winchester area, iLive is your local, medically supervised option. We serve patients from Frederick County, Clarke County, Warren County, Shenandoah County, and the Eastern Panhandle of West Virginia.
Call us at (540) 546-6442 or request your initial consultation online at 27 W Jubal Early Dr, Winchester, VA 22601.
If you are ready to explore whether tirzepatide is right for you, the first step is a conversation with an iLive medical provider. There is no obligation, no pressure, and no guesswork. Just a clear, personalized plan built around your health and your goals.
Mon-Thu: 8:00AM-6:00PM Friday: 8:00AM-12:00PM